The Latest in Lung Cancer

Oncology Practice

Immune checkpoint inhibition in SCLC: Modest outcomes, many questions

November 4, 2019

Oncology Practice

Patients have good recall on lung cancer screening scan benefits, not risks

October 26, 2019

Lung Cancer

Oncology Practice

Stereotactic body radiation therapy safe, effective for moderately central NSCLC

October 24, 2019

Lung Cancer

Oncology Practice

Adding ramucirumab extends PFS in EGFR-mutated lung cancer

October 23, 2019

Lung Cancer

Oncology Practice

Lazertinib has good showing in EGFR-mutated advanced NSCLC

October 23, 2019

Lung Cancer

The law of unintended consequences

October 11, 2019

NSCLC: Predicting benefit from immunotherapy plus chemo

September 30, 2019

Lung Cancer

Oncology Practice

Immunotherapy duo extends survival in first line for advanced NSCLC

September 29, 2019

Oncology Practice

Cardiotoxicity after checkpoint inhibitor treatment seen early, linked to elevated biomarkers

September 29, 2019

Lung Cancer

Oncology Practice

Osimertinib improves survival in advanced NSCLC

September 29, 2019

Oncology Practice

CheckMate 817: Nivo+ipi shows safety, efficacy across stage IV NSCLC subgroups

September 27, 2019

Lung Cancer

Oncology Practice

OS benefit with pembrolizumab endures long-term in advanced NSCLC

September 24, 2019

Oncology Practice

PACIFIC: Patterns of lung cancer progression suggest role for local ablative therapy

September 23, 2019

Lung Cancer

Oncology Practice

Adding radiation to immunotherapy may extend PFS in progressive lung cancer

September 23, 2019

Oncology Practice

Many institutions exceed recommended radiation doses during lung cancer screening

September 23, 2019